BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
hedge funds and large institutions have $177K invested in Biodexa Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
CL
1
CSS LLC
Chicago,
Illinois
|
$132K |
| 2 |
2
Goldman Sachs
New York
|
$35K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3K |
| 4 |
4
Group One Trading
Chicago,
Illinois
|
$2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $132K | -$118K | – | – |
|
|
2
Goldman Sachs
New York
| $35K | -$31K | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3K | -$2K | – | – |
|
|
5
Group One Trading
Chicago,
Illinois
| $2K | -$1K | – | – |
|